| Name | Title | Contact Details |
|---|---|---|
Matthew Keeling |
Director Of Information Technology | Profile |
The CEDES Group offers its innovative solutions for elevators, escalators, industrial doors, and warehouse management systems in more than 60 countries. We develop intelligent and safe sensing, control and communication devices that provide actionable data streams for higher operational and maintenance efficiency. Our product portfolio ranges from simple photoelectric sensors, through highly complex 3D camera systems in cutting-edge ToF (Time-of-Flight) technology, to complete safety-related control systems and smart IoT-enabling devices.
Kloeckner Metals - Americas is a prominent steel and metal distributor based in Roswell, Georgia. As the North American subsidiary of Klöckner & Co SE, it ranks as the fourth-largest metal service center in North America, operating around 50 locations across the U.S., Mexico, Canada, and Puerto Rico. The company serves approximately 8,000 metalworking businesses with a diverse portfolio of over 190,000 products, including carbon steel, stainless steel, and aluminum. The company offers extensive services beyond distribution, such as custom processing, warehousing, logistics solutions, and supply chain management. This comprehensive approach helps customers optimize production schedules and reduce lead times by providing materials close to their operations. Kloeckner Metals supports various industries, including automotive, construction, energy, and infrastructure, ensuring that its customers have access to the products and services they need for their projects.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Atomic Provisions is a restaurant group that exists to nourish our staff, guests and community with simple-perfected food and service...one slice, one biscuit, one ice cream and one beer at a time. We are growing...and with us you can grow too!
Bridge Specialty Group, LLC was launched in February 2021 by Brown & Brown, Inc. to encompass its broad portfolio of wholesale insurance businesses and is focused on bringing the power of its collective size and specialty to the wholesale brokerage marketplace. Composed of more than 25 boutique brands, Bridge Specialty Group is creating a more seamless way to connect the varying needs of our retail partners with the market clout and talents of our wholesale entities. To learn more about Bridge Specialty Group and our team of niche-focused brands, visit our website at bridgespecialtygroup.com.